Determinants of ESWT time variability in patients with COPD
A. Stoffels (Nijmegen (GE), Netherlands), J. Peters (Nijmegen (GE), Netherlands), M. Klaassen (Nijmegen (GE), Netherlands), H. Van Helvoort (Nijmegen (GE), Netherlands), R. Meys (Horn (LI), Netherlands), P. Klijn (Hilversum (NH), Netherlands), C. Burtin (Hasselt, Belgium), W. Derave (Ghent, Belgium), F. Franssen (Horn (LI), Netherlands), M. Spruit (Horn (LI), Netherlands), B. Van Den Borst (Nijmegen (GE), Netherlands), H. Van Hees (Nijmegen (GE), Netherlands)
Source: Virtual Congress 2020 – New insights into determinants of patient-reported outcomes in chronic respiratory diseases
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Stoffels (Nijmegen (GE), Netherlands), J. Peters (Nijmegen (GE), Netherlands), M. Klaassen (Nijmegen (GE), Netherlands), H. Van Helvoort (Nijmegen (GE), Netherlands), R. Meys (Horn (LI), Netherlands), P. Klijn (Hilversum (NH), Netherlands), C. Burtin (Hasselt, Belgium), W. Derave (Ghent, Belgium), F. Franssen (Horn (LI), Netherlands), M. Spruit (Horn (LI), Netherlands), B. Van Den Borst (Nijmegen (GE), Netherlands), H. Van Hees (Nijmegen (GE), Netherlands). Determinants of ESWT time variability in patients with COPD. 946
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Determinants of exacerbation rate in patients with stable COPD Source: Eur Respir J 2004; 24: Suppl. 48, 661s Year: 2004
Determinants of exercise capacity in patients with COPD Source: Annual Congress 2012 - The best posters on physical inactivity, muscle dysfunction and exercise intolerance Year: 2012
Determinants of exercise capacity in patients with COPD without other comorbidities Source: Annual Congress 2012 - Exercise capacity: from elite athletes to severe impairment Year: 2012
Variability in exacerbation frequency in COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 264s Year: 2002
Efficacy of tiotropium/olodaterol on sedentary/active time in COPD patients: VESUTO study Source: International Congress 2018 – COPD management Year: 2018
Impact of roflumilast treatment on the rate and duration of exacerbations and overall steroid load in patients with COPD Source: Annual Congress 2011 - COPD management Year: 2011
The influence of NIV on the pulse wave velocity in patients with the exacerbation of COPD Source: Annual Congress 2013 –COPD treatment Year: 2013
Assessment of exercise capacity in patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 294s Year: 2004
Lung function indices versus symptoms for monitoring the course of the disease in patients with COPD Source: Annual Congress 2008 - Functionality and metabolism in rehabilitation candidates Year: 2008
Evaluation of change in fatigue after pulmonary rehabilitation programme in COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 96s Year: 2007
Assessing the burden of repeated exacerbations among COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 64s Year: 2004
Efficiency of different multidimensional indexes for the assessment of the risk of exacerbations in patients with COPD Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020
Individual variation in the time course of symptoms during exercise in COPD Source: Annual Congress 2010 - Thoracic dynamics and dyspnoea on exercise Year: 2010
Sit-to-stand ability in patients hospitalised for acute exacerbation of COPD: Clinical characteristics and short-term outcomes Source: International Congress 2015 – New insights into exercise and muscle performance Year: 2015
Predictors of survival in severe COPD patients initiated on chronic NIV Source: International Congress 2016 – New horizons for noninvasive ventilation in acute and chronic settings Year: 2016
Impact of home hospitalization on treatment compliance in COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 207s Year: 2001
Change in BODE index, exacerbation duration and hospitalisation in a cohort of COPD patients Source: Annual Congress 2008 - Prognosis in COPD Year: 2008
Impact of onset time in patients with asthma Source: Eur Respir J 2003; 22: Suppl. 45, 480s Year: 2003
Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD Year: 2013
Predictors of benefit persistence after 6 months from a pulmonary rehabilitation programme in moderate-severe COPD patients Source: Annual Congress 2008 - Impact of rehabilitation programmes in COPD and non-COPD patients Year: 2008